Publicaciones

Publicaciones obtenidas automáticamente desde el perfil ORCID 0000-0002-5447-3554.

• Beyond bacilli: integrating the microbiome into the TB research agenda — Gut Microbes (2026)
• Younger age as a key predictor of follow‐up abandonment among PrEP users: A retrospective cohort study in Madrid — HIV Medicine (2026)
• Clarifying INSTINCT: Switching From Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Shows Comparable Inflammatory and Weight Outcomes — Clinical Infectious Diseases (2026)
• Interferon-Associated Inflammation and Galectin-9 Predict Risk of Non-AIDS Events and Mortality in Treated HIV (2026)
• Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study) — Clinical Infectious Diseases (2026)
• CURRENT TRENDS IN THE MANAGEMENT OF CYTOMEGALOVIRUS IN CELL THERAPIES RECIPIENTS IN SPAIN: RESULTS OF THE 2025 GETH-TC SURVEY — BONE MARROW TRANSPLANTATION (2026)
• Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics — FRONTIERS IN IMMUNOLOGY (2026)
• Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIV — INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2026)
• Mediterranean diet adherence is associated with antiviral, neuroimmune, and cardiometabolic proteomic profiles in people with HIV — FRONTIERS IN NUTRITION (2026)
• Prevalence and mortality of tuberculosis at HIV diagnosis in Spain, 2004-2024 — INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2026)
• Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor-Based Therapy in Naive Adults With HIV — OPEN FORUM INFECTIOUS DISEASES (2026)
• Towards tuberculosis elimination in people with HIV on antiretroviral therapy: evidence from a two-decade nationwide cohort in Spain — INFECTIOUS DISEASES OF POVERTY (2026)
• Lyophilised fecal microbiota transfer in capsules for recurrent Clostridioides difficile infection — International Journal of Antimicrobial Agents (2025)
• A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017 — Clinical Infectious Diseases (2025)
• Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size — International Journal of Molecular Sciences (2025)
• Galectin 9 Levels as a Potential Predictor of Intact HIV Reservoir Decay — The Journal of Infectious Diseases (2025)
• A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017 — medRxiv (2025)
• Cervical Microbiota Diversity and Functional Shifts in the Development of Cervical High-Grade Squamous Intraepithelial Lesions — medRxiv (2025)
• Cervical microbiota diversity and functional shifts in the development of cervical high-grade squamous intraepithelial lesions — FRONTIERS IN MEDICINE (2025)
• Chagas disease induces gut microbial metabolic stress: Disruption of energy and nucleotide pathways and partial reversal by antiparasitic therapy (TRIPOBIOME-2 study) — TRAVEL MEDICINE AND INFECTIOUS DISEASE (2025)
• Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size — SCIENTIFIC REPORTS (2025)
• Metaproteomics in the One Health Framework for Unraveling Microbial Effectors in Microbiomes — chemRxiv (2025)
• Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomes — MICROBIOME (2025)
• Predicting neurocognitive decline in older persons living with VIH: a spotlight on the T-CD4+/CD8+ratio — EUROPEAN GERIATRIC MEDICINE (2025)
• Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment — OPEN FORUM INFECTIOUS DISEASES (2025)
• CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis (vol 15, 1343124, 2024) — FRONTIERS IN IMMUNOLOGY (2024)
• CD4/CD8 ratio and CD8+T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis — FRONTIERS IN IMMUNOLOGY (2024)
• Chlamydia Trachomatis Prevalence in Asymptomatic Women in Madrid: Study Findings and Their Association with Risk Factors and Mental Health — BIOMEDICINES (2024)
• Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers — MICROBIOME (2024)
• From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy — MICROBIOME (2024)
• Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain — ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2024)
• Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer (vol 29, pg 1738, 2023) — NATURE MEDICINE (2024)
• Proteomic snapshot of saliva samples predicts new pathways implicated in SARS-CoV-2 pathogenesis — CLINICAL PROTEOMICS (2024)
• The Gut Microbiome: Another Piece in the Puzzle of HIV-Associated Atherosclerosis — JOURNAL OF INFECTIOUS DISEASES (2024)
• The microbiome as a biomarker of anal precancerous lesions in people with HIV — CURRENT OPINION IN INFECTIOUS DISEASES (2024)
• Unraveling Microbial Effectors: Metaproteomics in the One Health Framework — chemRxiv (2024)
• A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease — FRONTIERS IN IMMUNOLOGY (2023)
• Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression — OPEN FORUM INFECTIOUS DISEASES (2023)
• CD4/CD8 Ratio During Human Immunodeficiency Virus (HIV) Treatment: Time for Routine Monitoring? — CLINICAL INFECTIOUS DISEASES (2023)
• Chagas disease is related to structural changes of the gut microbiota in adults with chronic infection (TRIPOBIOME Study) — PLOS NEGLECTED TROPICAL DISEASES (2023)
• Contribution of Low CD4 Cell Counts and High Human Immunodeficiency Virus (HIV) Viral Load to the Efficacy of Preferred First-Line Antiretroviral Regimens for Treating HIV Infection: A Systematic Review and Meta-Analysis — CLINICAL INFECTIOUS DISEASES (2023)
• Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility — SCIENTIFIC REPORTS (2023)
• Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility (vol 13, 15124, 2023) — SCIENTIFIC REPORTS (2023)
• Diversity of immune responses in children highly exposed to SARS-CoV-2 — FRONTIERS IN IMMUNOLOGY (2023)
• Editorial: Targeting the microbiota to attenuate chronic inflammation — FRONTIERS IN IMMUNOLOGY (2023)
• Expanding HIV Clinical Monitoring: The Role of CD4, CD8, and CD4/CD8 Ratio in Predicting Non-AIDS Events. — medRxiv (2023)
• Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events — EBIOMEDICINE (2023)
• Folliculitis decalvans has a heterogeneous microbiological signature and impaired immunological response. — DERMATOLOGY (2023)
• From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications — PATHOGENS (2023)
• From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications — Preprints.org (2023)
• Global DNA methylation and telomere length as markers of accelerated aging in people living with HIV and non-alcoholic fatty liver disease — BMC GENOMICS (2023)
• Highlights of the first edition of the European Conference on Microbiota & Virology: A hybrid event, Paris, 23 March 2023 — JOURNAL OF VIRUS ERADICATION (2023)
• How the microbiome can help detect precancerous lesions and prevent anal cancer — NATURE MEDICINE (2023)
• Impact of administration of a latency reversal agent during initiation of antiretroviral treament on the HIV reservoir size — HIV MEDICINE (2023)
• Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study — CLINICAL INFECTIOUS DISEASES (2023)
• Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer — NATURE MEDICINE (2023)
• Patterns of substance use and their consequences on well-being among STI clinic patients — HIV MEDICINE (2023)
• Prevalence, characteristics, and associated risk factors of drug consumption and chemsex use among individuals attending an STI clinic (EpITs STUDY) — FRONTIERS IN PUBLIC HEALTH (2023)
• The Influence of Pre-Existing Immunity against Human Common Cold Coronaviruses on COVID-19 Susceptibility and Severity — MICROBIOLOGY RESEARCH (2023)
• The microbiota as a modulator of mucosal inflammation and HIV/HPV pathogenesis: From association to causation — FRONTIERS IN IMMUNOLOGY (2023)
• Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study (vol 13, 97664, 2022) — FRONTIERS IN IMMUNOLOGY (2023)
• Microbiome-Derived Cobalamin and Succinyl-CoA are Powerful Biomarkers for Improved Screening of Anal Cancer (2022)
• Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort. — HIV medicine (2022)
• A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment. — AIDS research and human retroviruses (2022)
• ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19 — FRONTIERS IN IMMUNOLOGY (2022)
• Comparison of the efficacy of preferred antiretroviral regimens in patients with CD4 cell counts <200 versus 200/L or VL >100 000 versus 100 000 copies/mL: a systematic review with meta-analysis. GESIDA-11520 Study — Journal of the International AIDS Society (2022)
• Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2 — JOURNAL OF INFECTION (2022)
• Effects of HIV Infection in Plasma Free Fatty Acid Profiles among People with Non-Alcoholic Fatty Liver Disease — JOURNAL OF CLINICAL MEDICINE (2022)
• Effects of advanced HIV disease on inflammation following ART initiation — JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)
• Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV — GUT MICROBES (2022)
• Knowledge, attitudes, and practices in chronic inflammation and cardiovascular risk associated with HIV infection in Spain — JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)
• Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens — FRONTIERS IN IMMUNOLOGY (2022)
• Management of Comorbidities in Treated HIV Infection: A Long Way to Go HIV, comorbidities and aging — INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
• Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis — JOURNAL OF PROTEOME RESEARCH (2022)
• Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults living with HIV: a multicentre prospective cohort study — JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)
• New-onset diabetes in persons with HIV on BIC/FTC/TAF in real-world clinical practice — JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)
• Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial — FRONTIERS IN PEDIATRICS (2022)
• Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events — EBIOMEDICINE (2022)
• Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV — NUTRIENTS (2022)
• Response to Commentary: Long-term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens — FRONTIERS IN IMMUNOLOGY (2022)
• Selective miRNA inhibition in CD8<SUP>+</SUP> cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses — FRONTIERS IN IMMUNOLOGY (2022)
• Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV — FRONTIERS IN IMMUNOLOGY (2022)
• Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial — NUTRIENTS (2022)
• Translating the observed differences in interleukin-6 levels between some antiretroviral regimens into potential long-term risk of serious non-AIDS events: A modeling study — FRONTIERS IN IMMUNOLOGY (2022)
• How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort. — BMC women's health (2021)
• A Retrospective Analysis of Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens (2021)
• Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients — JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
• Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men — JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
• Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery — JOURNAL OF INFECTIOUS DISEASES (2021)
• CD4⁺:CD8⁺ T-cell ratio changes in people with HIV receiving antiretroviral treatment — Antiviral Therapy (2021)
• COVID-19 and geographical area of origin — Clinical Microbiology and Infection (2021)
• Effect of the Use of Galectin-9 and Blockade of the TIM-3 Receptor in the Latent Cellular Reservoir of HIV-1 — JOURNAL OF VIROLOGY (2021)
• Effects of Two-Drug Regimens of Antiretroviral Therapy on Inflammatory Biomarkers in CoRIS: A Prospective Nested Cohort Study (2021)
• Effects of first- line anti-retroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study (vol 7, pg e567, 2020) — LANCET HIV (2021)
• Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study — CLINICAL MICROBIOLOGY AND INFECTION (2021)
• Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex With Men — JOURNAL OF INFECTIOUS DISEASES (2021)
• Fecal microbiota transplantation in HIV: A pilot placebo-controlled study — NATURE COMMUNICATIONS (2021)
• Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein — EMBO MOLECULAR MEDICINE (2021)
• Folliculitis decalvans microbiologic signature is specific for disease clinical phenotype — JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
• Implementation of a lung cancer screening initiative in HIV-infected subjects — PLOS ONE (2021)
• Metabolic snapshot of plasma samples reveals new pathways implicated in SARS-CoV-2 pathogenesis — bioRxiv (2021)
• Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers — EMERGING MICROBES & INFECTIONS (2021)
• Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial — The Lancet Respiratory Medicine (2021)
• The potential clinical impact of the observed differences in IL-6, a marker of inflammation, associated with some antiretroviral regimens — HIV MEDICINE (2021)
• Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study — JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)
• Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study. — The Journal of antimicrobial chemotherapy (2020)
• Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain. — The Journal of antimicrobial chemotherapy (2020)
• Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers — JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
• Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men — JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
• Changes in inflammatory biomarkers in SWORD-1 and SWORD-2 studies — LANCET HIV (2020)
• Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort — The Lancet HIV (2020)
• Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study — NUTRIENTS (2020)
• Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study — AIDS Research and Therapy (2020)
• Effects of Tocilizumab on Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study — medRxiv (2020)
• Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study — LANCET HIV (2020)
• Flow cytometry multiplexed method for the Detection of neutralizing human Antibodies to the native SARS-CoV-2 spike protein — medRxiv (2020)
• Impact of first-line antiretroviral therapy regimens on the restoration of the CD4/CD8 ratio in the CNICS cohort — JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
• Pneumococcal vaccination in adult people living with HIV on suppressive antiretroviral therapy: a case-control study — INTERNATIONAL JOURNAL OF STD & AIDS (2020)
• Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients — CLINICAL IMMUNOLOGY (2020)
• Reducing ART to less than 3-ARV regimen linked to increased systemic inflammation — JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2020)
• The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis — Clinical Infectious Diseases (2020)
• Travelling with HIV in the XXI century: Case report and narrative review — TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
• Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey — ECLINICALMEDICINE (2020)
• Atraumatic Incomplete Sternal Fracture Incidentally Detected in a Human Immunodeficiency Virus Patient at Lung Cancer Screening With Low-Dose Thoracic CT — JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2019)
• Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy — AIDS (2019)
• Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study) — CLINICAL INFECTIOUS DISEASES (2019)
• Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine — HIV MEDICINE (2019)
• HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases — FRONTIERS IN IMMUNOLOGY (2019)
• Immunonutrition in Human Immunodeficiency Virus Infection: Which Populations to Target? Reply — CLINICAL INFECTIOUS DISEASES (2019)
• Modulation of Saliva Microbiota through Prebiotic Intervention in HIV-Infected Individuals — NUTRIENTS (2019)
• [HIV in Spain 2017: policies for a new management of chronicity beyond virological control]. — Revista espanola de salud publica (2018)
• Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota — AIDS (2018)
• Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study) (vol 67, CIY414, 2018) — CLINICAL INFECTIOUS DISEASES (2018)
• HIV in Spain 2017: Policies for a new management of chronicity beyond virological control,VIH en España 2017: Políticas para una nueva gestión de la cronicidad más allá del control virológico — Revista Espanola de Salud Publica (2018)
• HIV in Spain 2017: policies for a new management of chronicity beyond virological control — REVISTA ESPANOLA DE SALUD PUBLICA (2018)
• Interplay between gut microbiota metabolism and inflammation in HIV infection — ISME JOURNAL (2018)
• Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4<SUP>+</SUP> T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy — JOURNAL OF VIROLOGY (2018)
• The functional consequences of the microbiome in HIV: insights from metabolomic studies — CURRENT OPINION IN HIV AND AIDS (2018)
• Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. — PLoS pathogens (2017)
• Concordance of Barthel Index, ECOG-PS, and Palliative Performance Scale in the assessment of functional status in patients with advanced medical diseases. — BMJ supportive & palliative care (2017)
• Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients — JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
• Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4/CD8 Ratio in Treatment-Naive HIV-Infected Individuals — ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
• HIV, HPV, and microbiota: partners in crime? — AIDS (2017)
• How can the gut microbiota affect immune recovery in HIV-infected individuals? — FUTURE MICROBIOLOGY (2017)
• Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM — PLOS ONE (2017)
• The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects — MUCOSAL IMMUNOLOGY (2017)
• Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy — JOURNAL OF INFECTIOUS DISEASES (2017)
• International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK. — Journal of the International AIDS Society (2016)
• Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients. — The Journal of antimicrobial chemotherapy (2016)
• Oral anticoagulation in patients with atrial fibrillation and medical non-neoplastic disease in a terminal stage. — Internal and emergency medicine (2016)
• Beyond Undetectable Viral Load: Effect of Nucleotides on Inflammation — EBIOMEDICINE (2016)
• Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy — AIDS (2016)
• Discontinuation of dolutegravir (DTG)-based regimens in clinical practice — JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2016)
• Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naive to Antiretroviral Therapy: A Pilot Randomized Trial — PLOS PATHOGENS (2016)
• Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naive to Antiretroviral Therapy: A Pilot Randomized Trial (vol 12, e1005381, 2016) — PLOS ONE (2016)
• Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals — EBIOMEDICINE (2016)
• HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases — SCIENTIFIC REPORTS (2016)
• Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions — OPEN FORUM INFECTIOUS DISEASES (2016)
• IL-15 promotes activation and expansion of CD8<SUP>+</SUP> T cells in HIV-1 infection — JOURNAL OF CLINICAL INVESTIGATION (2016)
• Prevalence of Elevated Blood Pressure in HIV-infected Children, Adolescents and Young Adults — PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
• Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals — MUCOSAL IMMUNOLOGY (2015)
• CD4/CD8 ratio: an emerging biomarker for HIV — LANCET HIV (2015)
• Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain — JOURNAL OF VIRAL HEPATITIS (2015)
• IL-15 drives CD8 T cell cycling and differentiation in chronic HIV-1 infection — JOURNAL OF IMMUNOLOGY (2015)
• Monitoring the CD4/CD8 ratio: A promising indicator of disease progression in HIV-infected individuals? — Future Virology (2015)
• Stroke in very old patients and ethics in clinical research Reply — MEDICINA CLINICA (2015)
• Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis. — Enfermedades infecciosas y microbiologia clinica (2014)
• Development of a six-month prognostic index in patients with advanced chronic medical conditions: the PALIAR score. — Journal of pain and symptom management (2014)
• Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities — ATHEROSCLEROSIS (2014)
• Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy — INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
• Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms — EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
• Functionally Defective High-Density Lipoproteins Are Related to Heightened T-Cell Activation in Vertically HIV-Infected Adolescents — JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
• HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality — PLOS PATHOGENS (2014)
• Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions. — PloS one (2014)
• Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio. — PloS one (2014)
• Subclinical Atherosclerosis and Markers of Immune Activation in HIV-Infected Children and Adolescents: The CaroVIH Study — JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
• The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery — HIV MEDICINE (2014)
• Author's Reply: Association of HIV-Infection and Antiretroviral Therapy with Levels of Endothelial Progenitor Cells and Subclinical Atherosclerosis — JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
• Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials — AIDS (2013)
• Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections — CLINICAL INFECTIOUS DISEASES (2013)
• Stroke in the very old: myths and realities — MEDICINA CLINICA (2013)
• The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults — AIDS (2013)
• The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression — JOURNAL OF INFECTION (2013)
• Association of HIV-Infection and Antiretroviral Therapy With Levels of Endothelial Progenitor Cells and Subclinical Atherosclerosis — JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
• Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection — MEDICINA CLINICA (2012)
• Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected Patients — JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
• The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis — PATHOGENS AND GLOBAL HEALTH (2012)